ArticleHealth economics review2024

Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran: a cost-effectiveness analysis.

Sara Kaveh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.